BioInvent International AB (BINV) - Financial and Strategic SWOT Analysis Review

BioInvent International AB (BINV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Highlights:

BioInvent International AB (BioInvent) is a biopharmaceutical company with focus on the research and development of antibody-based drugs for the treatment of diseases such as thrombosis, cancer, atherosclerosis, and ophthalmic. The company's product portfolio comprises three drug candidates in clinical development focusing on hematological cancers, namely, BI-505 to treat multiple myelomas, BI-1206 an antagonistic blocking antibody for the treatment of non-Hodgkin’s lymphoma and ACD-1013 is an agonistic activating immunostimulatory antibody for the treatment of Haematological cancer.

BioInvent International AB Key Recent Developments:

Feb 21, 2013: BioInvent Reports Revenue Of SEK9.3m In Q4 2012
Jan 09, 2013: BioInvent Announces Resignation Of Svein Mathisen As CEO
Oct 18, 2012: BioInvent Reports Revenue Of SEK12.9m In Q3 2012
Oct 02, 2012: BioInvent Announces Workforce Reduction
Jul 19, 2012: BioInvent Reports Revenue Of SEK6.2m In Q2 2012

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. SHOW LESS READ MORE >

List of Tables
List of Figures
Section 1 - About the Company
BioInvent International AB - Key Facts
BioInvent International AB - Key Employees
BioInvent International AB - Key Employee Biographies
BioInvent International AB - Major Products and Services
BioInvent International AB - Pharmaceutical Pipeline Products Data
BioInvent International AB, Pipeline Products by Therapy Area
BioInvent International AB, Pipeline Products by Development Phase
BioInvent International AB - History
BioInvent International AB - Company Statement
BioInvent International AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
BioInvent International AB - Business Description
BioInvent International AB - Corporate Strategy
BioInvent International AB - SWOT Analysis
SWOT Analysis - Overview
BioInvent International AB - Strengths
Strength - Proprietary Technology
Strength - Strong Research and Development Base
Strength - Orphan Drug Designation
BioInvent International AB - Weaknesses
Weakness - History of Losses
Weakness - Termination of Development Programs
BioInvent International AB - Opportunities
Opportunity - Product Pipeline
Opportunity - Rapidly Growing Segment-Antibodies
Opportunity - Market Potential- Hematological Cancers
BioInvent International AB - Threats
Threat - Biotechnology and Patent Risk
Threat - Growing Parallel Trade
Threat - Competitive Pressures
Threat - Uncertain R&D Outcomes
BioInvent International AB - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
BioInvent International AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
BioInvent International AB, Recent Developments
Feb 21, 2013: BioInvent Reports Revenue Of SEK9.3m In Q4 2012
Jan 09, 2013: BioInvent Announces Resignation Of Svein Mathisen As CEO
Oct 18, 2012: BioInvent Reports Revenue Of SEK12.9m In Q3 2012
Oct 02, 2012: BioInvent Announces Workforce Reduction
Jul 19, 2012: BioInvent Reports Revenue Of SEK6.2m In Q2 2012
May 02, 2012: BioInvent Reports Revenue Of SEK14.5m In Q1 2012
Feb 09, 2012: BioInvent Reports Revenue Of SEK1.8m In Q4 2011
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
BioInvent International AB, Key Facts
BioInvent International AB, Key Employees
BioInvent International AB, Key Employee Biographies
BioInvent International AB, Major Products and Services
BioInvent International AB, Number of Pipeline Products by Therapy Area
BioInvent International AB, Number of Pipeline Products by Development Stage
BioInvent International AB, Pipeline Products By Therapy Area and Development Phase
BioInvent International AB, History
BioInvent International AB, Subsidiaries
BioInvent International AB, Key Competitors
BioInvent International AB, Ratios based on current share price
BioInvent International AB, Annual Ratios
BioInvent International AB, Interim Ratios
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
BioInvent International AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
BioInvent International AB, Pipeline Products by Therapy Area
BioInvent International AB, Pipeline Products by Development Phase
BioInvent International AB, Performance Chart (2008 - 2012)
BioInvent International AB, Ratio Charts
BioInvent International AB, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
BioInvent International AB, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

Probi AB
Essum AB
MedCap AB
BioGaia AB
Dyax Corp.
Genmab A/S
PDL BioPharma, Inc.
ChronTech Pharma AB